Gubra A/S (GUBRA.CO)

DKK 728.0

(2.82%)

Operating Income Summary of Gubra A/S

  • Gubra A/S's latest annual operating income in 2023 was -49.41 Million DKK , down -628.56% from previous year.
  • Gubra A/S's latest quarterly operating income in 2024 Q1 was -12.92 Million DKK , down -1.3% from previous quarter.
  • Gubra A/S reported an annual operating income of 7.77 Million DKK in 2022, down -91.24% from previous year.
  • Gubra A/S reported an annual operating income of 88.78 Million DKK in 2021, up 490.06% from previous year.
  • Gubra A/S reported a quarterly operating income of -12.92 Million DKK for 2024 Q2, down 0.0% from previous quarter.
  • Gubra A/S reported a quarterly operating income of -11.4 Million DKK for 2023 Q1, down -11.76% from previous quarter.

Annual Operating Income Chart of Gubra A/S (2023 - 2020)

Historical Annual Operating Income of Gubra A/S (2023 - 2020)

Year Operating Income Operating Income Growth
2023 -49.41 Million DKK -628.56%
2022 7.77 Million DKK -91.24%
2021 88.78 Million DKK 490.06%
2020 15.04 Million DKK 0.0%

Peer Operating Income Comparison of Gubra A/S

Name Operating Income Operating Income Difference
ALK-Abelló A/S 666 Million DKK 107.42%
Bavarian Nordic A/S 1.49 Billion DKK 103.3%
Genmab A/S 5.32 Billion DKK 100.929%
Novo Nordisk A/S 102.57 Billion DKK 100.048%
Orphazyme A/S -27.04 Thousand DKK -182648.419%
Pharma Equity Group A/S -25.29 Million DKK -95.378%
Zealand Pharma A/S -572.23 Million DKK 91.364%